Pages that link to "Q66679472"
Jump to navigation
Jump to search
The following pages link to Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure (Q66679472):
Displaying 6 items.
- Updated recommendations of the International Dengue Initiative expert group for CYD-TDV vaccine implementation in Latin America (Q90082681) (← links)
- Analysis in a murine model points to IgG responses against the 34k2 salivary proteins from Aedes albopictus and Aedes aegypti as novel promising candidate markers of host exposure to Aedes mosquitoes (Q90744405) (← links)
- Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report (Q92385545) (← links)
- Economic evaluation and budget impact analysis of dengue vaccination following pre-vaccination serological screening in India (Q96638875) (← links)
- IgG Antibody Responses to the Aedes albopictus 34k2 Salivary Protein as Novel Candidate Marker of Human Exposure to the Tiger Mosquito (Q98771319) (← links)
- Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials (Q102206094) (← links)